FDA Authorizes Use of Novavax COVID-19 Vaccine, Adjuvanted in Adolescents
The Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for Novavax COVID-19 Vaccine, Adjuvanted to include…
Novavax Submits EUA Request for COVID-19 Vaccine Booster
An Emergency Use Authorization (EUA) request has been submitted to the US Food and Drug Administration (FDA) for the adjuvanted…
Novavax Submits EUA Request for COVID-19 Vaccine Booster
An Emergency Use Authorization (EUA) request has been submitted to the Food and Drug Administration (FDA) for the Novavax COVID-19…
Back to School: Time For COVID-19 Vaccinations
It’s back-to-school time in much of the United States. In addition to purchasing school supplies, parents are also scheduling physicals,…
FDA Authorizes COVID-19 Vaccines for Children as Young as 6 Months
Following a unanimous vote of support by the Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee,…
FDA Authorizes COVID-19 Vaccines for Children as Young as 6 Months
Following a unanimous vote of support by the Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee,…
FDA Panel Votes in Favor of EUA for Novavax COVID-19 Vaccine
The Food and Drug Administration (FDA)’s Vaccines and Related Biological Products Advisory Committee voted 21 to 0 (with 1 abstention)…
FDA Panel to Discuss COVID-19 Vaccine Booster Doses, Variants
The Food and Drug Administration (FDA) has scheduled a virtual meeting of its Vaccines and Related Biological Products Advisory Committee…
Evaluating Factors Involved in Willingness to Undergo COVID-19 Vaccination
Prosociality and willingness to undergo COVID-19 vaccination are associated, researchers in Poland observed in a random-intercept cross-lagged panel model (RI-CLPM).…
COVID19
COVID19 Vaccine
Immunization
Influenza
Medicine
Respiratory Diseases/Disorders
US
Vaccination
Does Heterologous COVID-19 Vaccination Protect Against Seasonal Coronaviruses?
Heterologous COVID-19 vaccination with the ChAdOx1 nCoV-19 and BNT162b2 vaccines increases in vitro neutralizing activity and may confer cross-protection against…